Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.04177026 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.04177026 |
3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.34162922 |
4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.11373400 |
5 | modulation by symbiont of host defense response (GO:0052031) | 5.11373400 |
6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.11373400 |
7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.11373400 |
8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.11373400 |
9 | modulation by symbiont of host immune response (GO:0052553) | 5.11373400 |
10 | * regulation of gamma-delta T cell differentiation (GO:0045586) | 4.98466903 |
11 | * positive regulation of gamma-delta T cell activation (GO:0046645) | 4.94072141 |
12 | detection of other organism (GO:0098543) | 4.55356622 |
13 | positive thymic T cell selection (GO:0045059) | 4.52842998 |
14 | * regulation of gamma-delta T cell activation (GO:0046643) | 4.37538333 |
15 | detection of bacterium (GO:0016045) | 4.35641717 |
16 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.23799034 |
17 | negative T cell selection (GO:0043383) | 4.19527012 |
18 | neutrophil activation involved in immune response (GO:0002283) | 4.16750228 |
19 | cellular extravasation (GO:0045123) | 4.15567949 |
20 | * negative regulation of erythrocyte differentiation (GO:0045647) | 4.11345598 |
21 | B cell receptor signaling pathway (GO:0050853) | 4.02038244 |
22 | macrophage activation involved in immune response (GO:0002281) | 4.02023453 |
23 | negative thymic T cell selection (GO:0045060) | 3.99444769 |
24 | response to peptidoglycan (GO:0032494) | 3.93638079 |
25 | negative regulation of T cell mediated immunity (GO:0002710) | 3.91396404 |
26 | detection of external biotic stimulus (GO:0098581) | 3.90998288 |
27 | positive T cell selection (GO:0043368) | 3.89628935 |
28 | negative regulation of cell killing (GO:0031342) | 3.87734174 |
29 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.87734174 |
30 | thymic T cell selection (GO:0045061) | 3.80082910 |
31 | detection of molecule of bacterial origin (GO:0032490) | 3.77200546 |
32 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.75420504 |
33 | germinal center formation (GO:0002467) | 3.66049631 |
34 | negative regulation of interleukin-12 production (GO:0032695) | 3.63309724 |
35 | T cell selection (GO:0045058) | 3.59838152 |
36 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.58753219 |
37 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.58168790 |
38 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.57888100 |
39 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.55849582 |
40 | positive regulation of histone deacetylation (GO:0031065) | 3.55554716 |
41 | response to muramyl dipeptide (GO:0032495) | 3.50879151 |
42 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.48319892 |
43 | response to host immune response (GO:0052572) | 3.44521927 |
44 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.44521927 |
45 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.44325792 |
46 | detection of biotic stimulus (GO:0009595) | 3.42288900 |
47 | * valine metabolic process (GO:0006573) | 3.41614835 |
48 | positive regulation of granulocyte differentiation (GO:0030854) | 3.40747690 |
49 | * response to interleukin-15 (GO:0070672) | 3.38498722 |
50 | alpha-linolenic acid metabolic process (GO:0036109) | 3.37631003 |
51 | tolerance induction (GO:0002507) | 3.37595073 |
52 | respiratory burst (GO:0045730) | 3.32254795 |
53 | neutrophil activation (GO:0042119) | 3.32073610 |
54 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.28157593 |
55 | immunoglobulin mediated immune response (GO:0016064) | 3.27197740 |
56 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.26891640 |
57 | response to host (GO:0075136) | 3.26891640 |
58 | response to host defenses (GO:0052200) | 3.26891640 |
59 | activated T cell proliferation (GO:0050798) | 3.26284946 |
60 | * JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.25292532 |
61 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.23303561 |
62 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.21765148 |
63 | regulation of mast cell degranulation (GO:0043304) | 3.20520751 |
64 | myeloid cell activation involved in immune response (GO:0002275) | 3.19232369 |
65 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.16617890 |
66 | L-phenylalanine catabolic process (GO:0006559) | 3.16617890 |
67 | regulation of cholesterol homeostasis (GO:2000188) | 3.15179388 |
68 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.15166240 |
69 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.15166240 |
70 | regulation of tolerance induction (GO:0002643) | 3.14015778 |
71 | lysine catabolic process (GO:0006554) | 3.12976515 |
72 | lysine metabolic process (GO:0006553) | 3.12976515 |
73 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.11743487 |
74 | negative regulation of phagocytosis (GO:0050765) | 3.11566869 |
75 | * 2-oxoglutarate metabolic process (GO:0006103) | 3.11305510 |
76 | microglial cell activation (GO:0001774) | 3.11121079 |
77 | L-phenylalanine metabolic process (GO:0006558) | 3.09487954 |
78 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.09487954 |
79 | type I interferon signaling pathway (GO:0060337) | 3.05842212 |
80 | cellular response to type I interferon (GO:0071357) | 3.05842212 |
81 | kynurenine metabolic process (GO:0070189) | 3.05782617 |
82 | response to type I interferon (GO:0034340) | 3.05268666 |
83 | leukocyte degranulation (GO:0043299) | 3.04536174 |
84 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.03565300 |
85 | growth hormone receptor signaling pathway (GO:0060396) | 3.01999986 |
86 | cellular response to interleukin-15 (GO:0071350) | 3.01346312 |
87 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.00806861 |
88 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.00333527 |
89 | protein carboxylation (GO:0018214) | 3.00333527 |
90 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.00057811 |
91 | macrophage activation (GO:0042116) | 2.98457939 |
92 | defense response to protozoan (GO:0042832) | 2.97882216 |
93 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.97735370 |
94 | granulocyte activation (GO:0036230) | 2.97453395 |
95 | complement activation, alternative pathway (GO:0006957) | 2.95596724 |
96 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.95582910 |
97 | * positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.93481912 |
98 | regulation of leukocyte degranulation (GO:0043300) | 2.92523899 |
99 | regulation of granulocyte differentiation (GO:0030852) | 2.91716383 |
100 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.91593461 |
101 | negative regulation of innate immune response (GO:0045824) | 2.90505897 |
102 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.88426089 |
103 | urea metabolic process (GO:0019627) | 2.86956419 |
104 | urea cycle (GO:0000050) | 2.86956419 |
105 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.85732440 |
106 | cysteine metabolic process (GO:0006534) | 2.82982301 |
107 | aromatic amino acid family catabolic process (GO:0009074) | 2.82297441 |
108 | neutrophil mediated immunity (GO:0002446) | 2.82052307 |
109 | positive regulation of tolerance induction (GO:0002645) | 2.80619579 |
110 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.80299595 |
111 | negative regulation of adaptive immune response (GO:0002820) | 2.80023608 |
112 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.78888515 |
113 | * regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.78883547 |
114 | * regulation of natural killer cell mediated immunity (GO:0002715) | 2.78883547 |
115 | interferon-gamma production (GO:0032609) | 2.78410471 |
116 | positive regulation of humoral immune response (GO:0002922) | 2.78116615 |
117 | negative regulation of type 2 immune response (GO:0002829) | 2.77911652 |
118 | regulation of regulatory T cell differentiation (GO:0045589) | 2.77671895 |
119 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.77339605 |
120 | T cell costimulation (GO:0031295) | 2.76413474 |
121 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.74028514 |
122 | negative regulation of fibrinolysis (GO:0051918) | 2.72710064 |
123 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.72280954 |
124 | T cell migration (GO:0072678) | 2.71802196 |
125 | regulation of T cell tolerance induction (GO:0002664) | 2.71530045 |
126 | regulation of response to interferon-gamma (GO:0060330) | 2.70300695 |
127 | lymphocyte costimulation (GO:0031294) | 2.69954091 |
128 | regulation of triglyceride catabolic process (GO:0010896) | 2.69553707 |
129 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.69330277 |
130 | negative regulation of cholesterol transport (GO:0032375) | 2.69317556 |
131 | negative regulation of sterol transport (GO:0032372) | 2.69317556 |
132 | NIK/NF-kappaB signaling (GO:0038061) | 2.68946925 |
133 | T cell receptor signaling pathway (GO:0050852) | 2.67234446 |
134 | fatty acid transmembrane transport (GO:1902001) | 2.64044523 |
135 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.62186601 |
136 | regulation of protein activation cascade (GO:2000257) | 2.61510152 |
137 | plasma lipoprotein particle assembly (GO:0034377) | 2.59679269 |
138 | * positive regulation of B cell differentiation (GO:0045579) | 2.59449929 |
139 | cellular response to growth hormone stimulus (GO:0071378) | 2.58965170 |
140 | sulfur amino acid catabolic process (GO:0000098) | 2.56261417 |
141 | protein-lipid complex assembly (GO:0065005) | 2.56001923 |
142 | nitrogen cycle metabolic process (GO:0071941) | 2.55582523 |
143 | * oxaloacetate metabolic process (GO:0006107) | 2.55545988 |
144 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.55172524 |
145 | phospholipid efflux (GO:0033700) | 2.54696145 |
146 | leukocyte aggregation (GO:0070486) | 2.53751036 |
147 | indole-containing compound catabolic process (GO:0042436) | 2.53566759 |
148 | indolalkylamine catabolic process (GO:0046218) | 2.53566759 |
149 | tryptophan catabolic process (GO:0006569) | 2.53566759 |
150 | positive regulation of protein deacetylation (GO:0090312) | 2.52063104 |
151 | carnitine shuttle (GO:0006853) | 2.51008663 |
152 | phospholipid homeostasis (GO:0055091) | 2.49864219 |
153 | bile acid biosynthetic process (GO:0006699) | 2.49445070 |
154 | * regulation of B cell differentiation (GO:0045577) | 2.48658108 |
155 | glyoxylate metabolic process (GO:0046487) | 2.48517571 |
156 | high-density lipoprotein particle remodeling (GO:0034375) | 2.47787252 |
157 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.46804265 |
158 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.46788711 |
159 | regulation of complement activation (GO:0030449) | 2.46100334 |
160 | ethanol oxidation (GO:0006069) | 2.45715430 |
161 | * tricarboxylic acid metabolic process (GO:0072350) | 2.45418611 |
162 | regulation of fibrinolysis (GO:0051917) | 2.40819269 |
163 | regulation of cholesterol storage (GO:0010885) | 2.40511812 |
164 | plasma lipoprotein particle clearance (GO:0034381) | 2.40179803 |
165 | regulation of fatty acid oxidation (GO:0046320) | 2.39238559 |
166 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.38606732 |
167 | tryptophan metabolic process (GO:0006568) | 2.37957830 |
168 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.35568020 |
169 | positive regulation of lipid catabolic process (GO:0050996) | 2.34988042 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.78197461 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.04769291 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.74733359 |
4 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.40378115 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.35317417 |
6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.29490921 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.29466995 |
8 | MYC_22102868_ChIP-Seq_BL_Human | 3.13835421 |
9 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.98639060 |
10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.74053618 |
11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.51294719 |
12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.48492276 |
13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.48029842 |
14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.42624910 |
15 | MAF_26560356_Chip-Seq_TH1_Human | 2.40284050 |
16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.39786827 |
17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.37163038 |
18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.35599068 |
19 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.25598960 |
20 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.24368927 |
21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.16265036 |
22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.16106204 |
23 | UTX_26944678_Chip-Seq_JUKART_Human | 2.14203514 |
24 | MYB_26560356_Chip-Seq_TH2_Human | 2.07551368 |
25 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.07483002 |
26 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.05118574 |
27 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02929386 |
28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.02474802 |
29 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.00103116 |
30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.97098649 |
31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.95241469 |
32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93795878 |
33 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.88678344 |
34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.88346152 |
35 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.87288060 |
36 | * MYB_26560356_Chip-Seq_TH1_Human | 1.87259603 |
37 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.85938686 |
38 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.85445895 |
39 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85129338 |
40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.81282799 |
41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.80363782 |
42 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.76633011 |
43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.76377990 |
44 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.75837627 |
45 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.74262388 |
46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.71397813 |
47 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.70655057 |
48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.62576987 |
49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.59472440 |
50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.58470869 |
51 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.55565333 |
52 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54852396 |
53 | MAF_26560356_Chip-Seq_TH2_Human | 1.54538437 |
54 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.51645242 |
55 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50596840 |
56 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.49060675 |
57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48764601 |
58 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.42786743 |
59 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.37777927 |
60 | SPI1_23127762_ChIP-Seq_K562_Human | 1.36982221 |
61 | GATA1_19941826_ChIP-Seq_K562_Human | 1.35518267 |
62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.34964731 |
63 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30971918 |
64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30050654 |
65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.29454114 |
66 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.27706877 |
67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26420285 |
68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25125781 |
69 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.22558801 |
70 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.19011871 |
71 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18235409 |
72 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15025567 |
73 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.14715644 |
74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14170089 |
75 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.13825391 |
76 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12479148 |
77 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11786015 |
78 | GATA2_19941826_ChIP-Seq_K562_Human | 1.11264711 |
79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.11106666 |
80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11009032 |
81 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09998351 |
82 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07975274 |
83 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07965018 |
84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07820188 |
85 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.07766458 |
86 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07068936 |
87 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06218255 |
88 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.04797954 |
89 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03646162 |
90 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03194986 |
91 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03102536 |
92 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.02158591 |
93 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01213880 |
94 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01047787 |
95 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00537491 |
96 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00525461 |
97 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.99443571 |
98 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98533577 |
99 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.98007315 |
100 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97756656 |
101 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97750621 |
102 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97750621 |
103 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.96211520 |
104 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94298450 |
105 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93651813 |
106 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.92911345 |
107 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.90681593 |
108 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.90380172 |
109 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90208421 |
110 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.89291046 |
111 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.89093638 |
112 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.88765590 |
113 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.87993570 |
114 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87611746 |
115 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86713083 |
116 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.86522882 |
117 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86355608 |
118 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85928382 |
119 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85417199 |
120 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85409438 |
121 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84886510 |
122 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.84714394 |
123 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84634447 |
124 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.83985340 |
125 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83937283 |
126 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83810091 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 3.21558063 |
2 | MP0005360_urolithiasis | 3.09054599 |
3 | MP0000685_abnormal_immune_system | 2.77646346 |
4 | MP0003300_gastrointestinal_ulcer | 2.74344234 |
5 | MP0005365_abnormal_bile_salt | 2.74271879 |
6 | MP0003763_abnormal_thymus_physiology | 2.65936684 |
7 | MP0001835_abnormal_antigen_presentation | 2.31311497 |
8 | MP0005085_abnormal_gallbladder_physiolo | 2.25691278 |
9 | MP0003436_decreased_susceptibility_to | 2.22091613 |
10 | MP0002166_altered_tumor_susceptibility | 2.20260861 |
11 | MP0005451_abnormal_body_composition | 2.18498348 |
12 | MP0001790_abnormal_immune_system | 2.13726317 |
13 | MP0005387_immune_system_phenotype | 2.13726317 |
14 | MP0001800_abnormal_humoral_immune | 2.09199010 |
15 | MP0005671_abnormal_response_to | 2.08837530 |
16 | MP0009840_abnormal_foam_cell | 2.06949742 |
17 | MP0003303_peritoneal_inflammation | 2.05563956 |
18 | MP0004130_abnormal_muscle_cell | 1.91896847 |
19 | MP0003252_abnormal_bile_duct | 1.88073914 |
20 | MP0008260_abnormal_autophagy | 1.86093708 |
21 | MP0003828_pulmonary_edema | 1.80767677 |
22 | MP0002138_abnormal_hepatobiliary_system | 1.80317401 |
23 | MP0003191_abnormal_cellular_cholesterol | 1.79506751 |
24 | MP0009785_altered_susceptibility_to | 1.78972251 |
25 | MP0010329_abnormal_lipoprotein_level | 1.78574818 |
26 | MP0005000_abnormal_immune_tolerance | 1.77551896 |
27 | MP0003172_abnormal_lysosome_physiology | 1.74421450 |
28 | * MP0000609_abnormal_liver_physiology | 1.71727540 |
29 | MP0004510_myositis | 1.71383221 |
30 | * MP0002723_abnormal_immune_serum | 1.70643141 |
31 | MP0005464_abnormal_platelet_physiology | 1.69492027 |
32 | MP0005025_abnormal_response_to | 1.68618852 |
33 | MP0002132_abnormal_respiratory_system | 1.67187493 |
34 | MP0001873_stomach_inflammation | 1.67020011 |
35 | MP0004947_skin_inflammation | 1.65797537 |
36 | MP0004381_abnormal_hair_follicle | 1.65569361 |
37 | MP0010155_abnormal_intestine_physiology | 1.62460773 |
38 | MP0003724_increased_susceptibility_to | 1.61863166 |
39 | MP0002396_abnormal_hematopoietic_system | 1.61704984 |
40 | * MP0002398_abnormal_bone_marrow | 1.61339329 |
41 | MP0002452_abnormal_antigen_presenting | 1.61120191 |
42 | MP0001853_heart_inflammation | 1.59472655 |
43 | MP0008875_abnormal_xenobiotic_pharmacok | 1.59265496 |
44 | * MP0002420_abnormal_adaptive_immunity | 1.58348828 |
45 | MP0002837_dystrophic_cardiac_calcinosis | 1.56832560 |
46 | * MP0001819_abnormal_immune_cell | 1.56414633 |
47 | MP0005083_abnormal_biliary_tract | 1.53399298 |
48 | MP0002405_respiratory_system_inflammati | 1.49553324 |
49 | MP0008961_abnormal_basal_metabolism | 1.49286940 |
50 | MP0001851_eye_inflammation | 1.45965326 |
51 | * MP0000716_abnormal_immune_system | 1.44076240 |
52 | MP0003705_abnormal_hypodermis_morpholog | 1.43819185 |
53 | MP0002006_tumorigenesis | 1.43472545 |
54 | MP0003806_abnormal_nucleotide_metabolis | 1.41054621 |
55 | * MP0002419_abnormal_innate_immunity | 1.39435881 |
56 | MP0003866_abnormal_defecation | 1.38377269 |
57 | MP0009278_abnormal_bone_marrow | 1.38020150 |
58 | * MP0000689_abnormal_spleen_morphology | 1.37849238 |
59 | * MP0001845_abnormal_inflammatory_respons | 1.37382228 |
60 | * MP0002722_abnormal_immune_system | 1.36713356 |
61 | * MP0000703_abnormal_thymus_morphology | 1.34403881 |
62 | * MP0008469_abnormal_protein_level | 1.32626207 |
63 | MP0003656_abnormal_erythrocyte_physiolo | 1.32577580 |
64 | MP0006082_CNS_inflammation | 1.29924706 |
65 | MP0000858_altered_metastatic_potential | 1.26917527 |
66 | MP0004808_abnormal_hematopoietic_stem | 1.26364331 |
67 | MP0001666_abnormal_nutrient_absorption | 1.21861668 |
68 | * MP0002429_abnormal_blood_cell | 1.21505872 |
69 | MP0009333_abnormal_splenocyte_physiolog | 1.20402487 |
70 | MP0005397_hematopoietic_system_phenotyp | 1.20280077 |
71 | MP0001545_abnormal_hematopoietic_system | 1.20280077 |
72 | MP0005319_abnormal_enzyme/_coenzyme | 1.18691174 |
73 | MP0002998_abnormal_bone_remodeling | 1.18238334 |
74 | MP0005670_abnormal_white_adipose | 1.15114423 |
75 | MP0002933_joint_inflammation | 1.13146165 |
76 | MP0005666_abnormal_adipose_tissue | 1.13069357 |
77 | MP0003690_abnormal_glial_cell | 1.13028434 |
78 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.12882065 |
79 | MP0004036_abnormal_muscle_relaxation | 1.11112382 |
80 | * MP0002118_abnormal_lipid_homeostasis | 1.10872841 |
81 | MP0004883_abnormal_blood_vessel | 1.10096895 |
82 | MP0002148_abnormal_hypersensitivity_rea | 1.08762234 |
83 | MP0002009_preneoplasia | 1.08417673 |
84 | MP0004185_abnormal_adipocyte_glucose | 1.07143799 |
85 | MP0005310_abnormal_salivary_gland | 1.06914569 |
86 | MP0001533_abnormal_skeleton_physiology | 1.04730152 |
87 | MP0009764_decreased_sensitivity_to | 1.04555380 |
88 | MP0002971_abnormal_brown_adipose | 1.02497525 |
89 | MP0000465_gastrointestinal_hemorrhage | 1.00840399 |
90 | MP0000747_muscle_weakness | 1.00208026 |
91 | MP0005332_abnormal_amino_acid | 0.99833494 |
92 | MP0003868_abnormal_feces_composition | 0.99694662 |
93 | MP0003646_muscle_fatigue | 0.99339302 |
94 | MP0009763_increased_sensitivity_to | 0.98498937 |
95 | * MP0000598_abnormal_liver_morphology | 0.97229688 |
96 | MP0003183_abnormal_peptide_metabolism | 0.95091351 |
97 | MP0005058_abnormal_lysosome_morphology | 0.94883990 |
98 | MP0002877_abnormal_melanocyte_morpholog | 0.94865141 |
99 | MP0004087_abnormal_muscle_fiber | 0.93177682 |
100 | MP0000751_myopathy | 0.90694387 |
101 | * MP0009643_abnormal_urine_homeostasis | 0.90599531 |
102 | MP0000749_muscle_degeneration | 0.90386294 |
103 | MP0010352_gastrointestinal_tract_polyps | 0.89945762 |
104 | MP0002269_muscular_atrophy | 0.89760526 |
105 | MP0004084_abnormal_cardiac_muscle | 0.88215847 |
106 | MP0003075_altered_response_to | 0.87996311 |
107 | MP0005375_adipose_tissue_phenotype | 0.87219991 |
108 | MP0003045_fibrosis | 0.86448331 |
109 | MP0008004_abnormal_stomach_pH | 0.84718745 |
110 | MP0001663_abnormal_digestive_system | 0.83842353 |
111 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82408069 |
112 | MP0002277_abnormal_respiratory_mucosa | 0.80500504 |
113 | MP0005076_abnormal_cell_differentiation | 0.80355980 |
114 | MP0006036_abnormal_mitochondrial_physio | 0.80326654 |
115 | MP0003195_calcinosis | 0.80239258 |
116 | MP0005166_decreased_susceptibility_to | 0.80035332 |
117 | MP0000604_amyloidosis | 0.79870066 |
118 | MP0005330_cardiomyopathy | 0.79294699 |
119 | MP0005075_abnormal_melanosome_morpholog | 0.78711641 |
120 | MP0005164_abnormal_response_to | 0.78574256 |
121 | * MP0002078_abnormal_glucose_homeostasis | 0.78055421 |
122 | MP0010630_abnormal_cardiac_muscle | 0.77144776 |
123 | * MP0005334_abnormal_fat_pad | 0.76951241 |
124 | MP0000490_abnormal_crypts_of | 0.75607369 |
125 | MP0003448_altered_tumor_morphology | 0.74581235 |
126 | MP0009115_abnormal_fat_cell | 0.73638244 |
127 | MP0003091_abnormal_cell_migration | 0.71883019 |
128 | MP0005390_skeleton_phenotype | 0.67540730 |
129 | MP0000249_abnormal_blood_vessel | 0.65746317 |
130 | MP0008874_decreased_physiological_sensi | 0.65109298 |
131 | * MP0002019_abnormal_tumor_incidence | 0.63940030 |
132 | MP0003795_abnormal_bone_structure | 0.61678311 |
133 | MP0000015_abnormal_ear_pigmentation | 0.60218399 |
134 | MP0000343_altered_response_to | 0.56791224 |
135 | MP0008057_abnormal_DNA_replication | 0.56515111 |
136 | MP0009765_abnormal_xenobiotic_induced | 0.55346264 |
137 | MP0001348_abnormal_lacrimal_gland | 0.54873066 |
138 | MP0002332_abnormal_exercise_endurance | 0.54066837 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 4.76879227 |
2 | Recurrent bacterial skin infections (HP:0005406) | 4.70385380 |
3 | Orchitis (HP:0100796) | 4.57700878 |
4 | Retrobulbar optic neuritis (HP:0100654) | 4.30913832 |
5 | Optic neuritis (HP:0100653) | 4.30913832 |
6 | Abnormality of macrophages (HP:0004311) | 4.16372916 |
7 | Stomatitis (HP:0010280) | 3.89821463 |
8 | T lymphocytopenia (HP:0005403) | 3.70769478 |
9 | Deep venous thrombosis (HP:0002625) | 3.70214964 |
10 | Obstructive lung disease (HP:0006536) | 3.68075457 |
11 | Chronic obstructive pulmonary disease (HP:0006510) | 3.68075457 |
12 | Abnormality of T cell number (HP:0011839) | 3.54213739 |
13 | Mediastinal lymphadenopathy (HP:0100721) | 3.51873953 |
14 | Encephalitis (HP:0002383) | 3.44889931 |
15 | Keratoconjunctivitis sicca (HP:0001097) | 3.41865770 |
16 | Recurrent viral infections (HP:0004429) | 3.31860028 |
17 | Recurrent fungal infections (HP:0002841) | 3.16267753 |
18 | Vasculitis (HP:0002633) | 3.15257249 |
19 | Gingivitis (HP:0000230) | 3.13971232 |
20 | Exercise-induced myalgia (HP:0003738) | 3.09265274 |
21 | Keratoconjunctivitis (HP:0001096) | 3.07995416 |
22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.03358477 |
23 | Chest pain (HP:0100749) | 3.02393422 |
24 | Panhypogammaglobulinemia (HP:0003139) | 3.01163003 |
25 | Xanthomatosis (HP:0000991) | 2.99086457 |
26 | Abnormality of the common coagulation pathway (HP:0010990) | 2.93378622 |
27 | Myoglobinuria (HP:0002913) | 2.92497275 |
28 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.89334616 |
29 | Abnormality of T cells (HP:0002843) | 2.87534777 |
30 | Nasal polyposis (HP:0100582) | 2.82778285 |
31 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.80084577 |
32 | Chronic otitis media (HP:0000389) | 2.78178674 |
33 | Intrahepatic cholestasis (HP:0001406) | 2.76251874 |
34 | Exercise-induced muscle cramps (HP:0003710) | 2.75997446 |
35 | Complement deficiency (HP:0004431) | 2.75084650 |
36 | Urticaria (HP:0001025) | 2.74283996 |
37 | Eczematoid dermatitis (HP:0000976) | 2.73419413 |
38 | Abnormality of the nasal mucosa (HP:0000433) | 2.72551960 |
39 | Granulocytopenia (HP:0001913) | 2.72330354 |
40 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.70562721 |
41 | Hypochromic microcytic anemia (HP:0004840) | 2.70086967 |
42 | Hypoglycemic coma (HP:0001325) | 2.68035588 |
43 | Pulmonary infiltrates (HP:0002113) | 2.62491375 |
44 | Hemoptysis (HP:0002105) | 2.61861864 |
45 | Hypochromic anemia (HP:0001931) | 2.61038900 |
46 | Myocardial infarction (HP:0001658) | 2.60745053 |
47 | Spontaneous hematomas (HP:0007420) | 2.59014507 |
48 | Leukocytosis (HP:0001974) | 2.58826667 |
49 | Hyperlipoproteinemia (HP:0010980) | 2.58573658 |
50 | Gingival bleeding (HP:0000225) | 2.57354017 |
51 | Ketosis (HP:0001946) | 2.57278512 |
52 | Gastrointestinal inflammation (HP:0004386) | 2.50475184 |
53 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.49547075 |
54 | Joint hemorrhage (HP:0005261) | 2.49481698 |
55 | Inflammation of the large intestine (HP:0002037) | 2.48434326 |
56 | Osteomyelitis (HP:0002754) | 2.46637132 |
57 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.46594496 |
58 | Recurrent cutaneous fungal infections (HP:0011370) | 2.46594496 |
59 | Episodic fever (HP:0001954) | 2.45859643 |
60 | IgM deficiency (HP:0002850) | 2.44414108 |
61 | Recurrent bronchitis (HP:0002837) | 2.43108147 |
62 | Agammaglobulinemia (HP:0004432) | 2.42919205 |
63 | Prolonged partial thromboplastin time (HP:0003645) | 2.42635789 |
64 | Colitis (HP:0002583) | 2.42179161 |
65 | Lymphopenia (HP:0001888) | 2.41468218 |
66 | Slow saccadic eye movements (HP:0000514) | 2.40011666 |
67 | Epistaxis (HP:0000421) | 2.39387298 |
68 | Ketoacidosis (HP:0001993) | 2.33267212 |
69 | Abnormality of the fingertips (HP:0001211) | 2.30222819 |
70 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.29983064 |
71 | Hyporeflexia of lower limbs (HP:0002600) | 2.29831601 |
72 | Hypobetalipoproteinemia (HP:0003563) | 2.28672572 |
73 | Abnormality of T cell physiology (HP:0011840) | 2.28303104 |
74 | Rhabdomyolysis (HP:0003201) | 2.27887113 |
75 | Polycythemia (HP:0001901) | 2.27799611 |
76 | Increased IgM level (HP:0003496) | 2.26545717 |
77 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.26414617 |
78 | Peritonitis (HP:0002586) | 2.26352752 |
79 | Viral hepatitis (HP:0006562) | 2.25925317 |
80 | Asymmetric septal hypertrophy (HP:0001670) | 2.25359079 |
81 | Autoimmune hemolytic anemia (HP:0001890) | 2.24356027 |
82 | Verrucae (HP:0200043) | 2.23612239 |
83 | Papilloma (HP:0012740) | 2.23612239 |
84 | Microcytic anemia (HP:0001935) | 2.23446521 |
85 | Ulnar deviation of the wrist (HP:0003049) | 2.22473135 |
86 | Muscle fiber inclusion bodies (HP:0100299) | 2.22210735 |
87 | Abnormal platelet volume (HP:0011876) | 2.22185304 |
88 | Hypoplasia of the thymus (HP:0000778) | 2.21286526 |
89 | Abnormality of the peritoneum (HP:0002585) | 2.20357110 |
90 | Increased density of long bones (HP:0006392) | 2.20177268 |
91 | Hyperammonemia (HP:0001987) | 2.17911613 |
92 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.17606172 |
93 | Abnormal platelet function (HP:0011869) | 2.17505474 |
94 | Impaired platelet aggregation (HP:0003540) | 2.17505474 |
95 | Gastrointestinal infarctions (HP:0005244) | 2.15902906 |
96 | Abnormality of B cell number (HP:0010975) | 2.15067834 |
97 | B lymphocytopenia (HP:0010976) | 2.15067834 |
98 | Anorexia (HP:0002039) | 2.14641200 |
99 | Frequent falls (HP:0002359) | 2.14034908 |
100 | Prolonged bleeding time (HP:0003010) | 2.13721842 |
101 | Metaphyseal cupping (HP:0003021) | 2.13529286 |
102 | Hypoalphalipoproteinemia (HP:0003233) | 2.11674961 |
103 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.11443626 |
104 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.11431292 |
105 | Autoimmune thrombocytopenia (HP:0001973) | 2.10435478 |
106 | Menorrhagia (HP:0000132) | 2.10100916 |
107 | Joint swelling (HP:0001386) | 2.09508085 |
108 | Gastrointestinal stroma tumor (HP:0100723) | 2.09018812 |
109 | Fatigue (HP:0012378) | 2.08662730 |
110 | Myositis (HP:0100614) | 2.07931825 |
111 | Sepsis (HP:0100806) | 2.06943154 |
112 | Petechiae (HP:0000967) | 2.06496771 |
113 | Abnormality of complement system (HP:0005339) | 2.05062077 |
114 | Hypolipoproteinemia (HP:0010981) | 2.05017868 |
115 | Late onset (HP:0003584) | 2.03723521 |
116 | Increased mean platelet volume (HP:0011877) | 2.03691779 |
117 | Pulmonary embolism (HP:0002204) | 2.02435180 |
118 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.02258469 |
119 | Abnormality of the endocardium (HP:0004306) | 2.02228905 |
120 | Abnormality of the pleura (HP:0002103) | 2.02168476 |
121 | Severe combined immunodeficiency (HP:0004430) | 2.01907814 |
122 | Type 1 muscle fiber predominance (HP:0003803) | 2.01782447 |
123 | Recurrent skin infections (HP:0001581) | 2.00357129 |
124 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.00264617 |
125 | Abnormality of the intrinsic pathway (HP:0010989) | 2.00082455 |
126 | Combined immunodeficiency (HP:0005387) | 2.00066168 |
127 | Esophageal varix (HP:0002040) | 1.99090911 |
128 | Cholelithiasis (HP:0001081) | 1.98905973 |
129 | Papilledema (HP:0001085) | 1.98736920 |
130 | Increased connective tissue (HP:0009025) | 1.97452188 |
131 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.96658193 |
132 | Mitral stenosis (HP:0001718) | 1.96350488 |
133 | Hypergammaglobulinemia (HP:0010702) | 1.93285891 |
134 | Difficulty running (HP:0009046) | 1.92586441 |
135 | Hyperbilirubinemia (HP:0002904) | 1.92221546 |
136 | Acute hepatic failure (HP:0006554) | 1.91448523 |
137 | Acne (HP:0001061) | 1.90813045 |
138 | Eosinophilia (HP:0001880) | 1.90618291 |
139 | Skin ulcer (HP:0200042) | 1.90567125 |
140 | Arterial thrombosis (HP:0004420) | 1.90458283 |
141 | Increased IgE level (HP:0003212) | 1.89508489 |
142 | Chronic diarrhea (HP:0002028) | 1.89418788 |
143 | Thrombocytosis (HP:0001894) | 1.88775044 |
144 | Meningitis (HP:0001287) | 1.87914692 |
145 | Abnormal gallbladder morphology (HP:0012437) | 1.86830844 |
146 | Pustule (HP:0200039) | 1.86695489 |
147 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.86420697 |
148 | Subaortic stenosis (HP:0001682) | 1.86420697 |
149 | Calf muscle hypertrophy (HP:0008981) | 1.85912946 |
150 | Cellulitis (HP:0100658) | 1.85227358 |
151 | Subacute progressive viral hepatitis (HP:0006572) | 1.85103843 |
152 | Cerebral aneurysm (HP:0004944) | 1.84814047 |
153 | Glomerulopathy (HP:0100820) | 1.83581465 |
154 | Gangrene (HP:0100758) | 1.81429248 |
155 | Amyloidosis (HP:0011034) | 1.79071331 |
156 | Purpura (HP:0000979) | 1.77538892 |
157 | Hypertensive crisis (HP:0100735) | 1.77023084 |
158 | Vertigo (HP:0002321) | 1.74992973 |
159 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.74565047 |
160 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.73856626 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 4.60299435 |
2 | MAP4K1 | 4.06798412 |
3 | TRIB3 | 3.64583183 |
4 | PRPF4B | 3.42054850 |
5 | EEF2K | 3.09144956 |
6 | PKN2 | 3.08681560 |
7 | FGFR4 | 2.92244590 |
8 | JAK3 | 2.67383411 |
9 | ERN1 | 2.50449927 |
10 | TTN | 2.49733340 |
11 | MAP3K10 | 2.36656424 |
12 | TXK | 2.21937566 |
13 | SIK1 | 2.18132805 |
14 | TAOK3 | 2.08265258 |
15 | ZAP70 | 2.07889605 |
16 | ITK | 2.07162394 |
17 | JAK1 | 1.93207643 |
18 | MAP2K3 | 1.85261579 |
19 | KSR2 | 1.83560906 |
20 | EPHB1 | 1.82001287 |
21 | TBK1 | 1.81150027 |
22 | FLT3 | 1.67412721 |
23 | FGFR3 | 1.63627385 |
24 | GRK6 | 1.62343127 |
25 | MAP3K14 | 1.61482470 |
26 | IKBKE | 1.61301442 |
27 | MAP3K7 | 1.60615220 |
28 | STK10 | 1.58522272 |
29 | BCKDK | 1.51716896 |
30 | * TYK2 | 1.51631992 |
31 | BTK | 1.51530159 |
32 | LRRK2 | 1.35383306 |
33 | SMG1 | 1.25759467 |
34 | TGFBR2 | 1.23671542 |
35 | KIT | 1.23561116 |
36 | EPHA3 | 1.22886546 |
37 | CSK | 1.22466898 |
38 | MARK2 | 1.20261990 |
39 | * JAK2 | 1.19480635 |
40 | TEC | 1.18628811 |
41 | SYK | 1.13913307 |
42 | NLK | 1.13123403 |
43 | LCK | 1.09058346 |
44 | MAP3K13 | 1.08492460 |
45 | FGR | 1.05360055 |
46 | RIPK1 | 1.05150787 |
47 | YES1 | 1.00487625 |
48 | PIK3CG | 0.99231762 |
49 | CSF1R | 0.99072274 |
50 | KDR | 0.96916781 |
51 | PRKCH | 0.94539375 |
52 | OBSCN | 0.93335053 |
53 | * HCK | 0.93236944 |
54 | IRAK1 | 0.89125474 |
55 | CAMK1D | 0.88280725 |
56 | SIK3 | 0.87132035 |
57 | TAOK2 | 0.86373207 |
58 | IKBKB | 0.85951462 |
59 | MAP3K6 | 0.85366483 |
60 | * PTK6 | 0.83861711 |
61 | HIPK2 | 0.83720150 |
62 | RAF1 | 0.81166134 |
63 | MAP3K2 | 0.80499149 |
64 | BMPR2 | 0.79965416 |
65 | MAPK11 | 0.79230083 |
66 | NEK9 | 0.78946723 |
67 | BLK | 0.78399639 |
68 | SIK2 | 0.78136224 |
69 | RET | 0.77633928 |
70 | CHUK | 0.75539357 |
71 | MAPK12 | 0.73827574 |
72 | PDPK1 | 0.73793248 |
73 | CAMK1G | 0.73695465 |
74 | CDC42BPA | 0.72360817 |
75 | DMPK | 0.71964980 |
76 | RPS6KA4 | 0.69784835 |
77 | PIM1 | 0.69520688 |
78 | TAOK1 | 0.69498123 |
79 | IRAK3 | 0.67949839 |
80 | MAPK7 | 0.66668858 |
81 | SCYL2 | 0.65984642 |
82 | PRKAA2 | 0.65891409 |
83 | CDK4 | 0.65297054 |
84 | MARK3 | 0.64841363 |
85 | WNK1 | 0.64485075 |
86 | PRKCQ | 0.64070119 |
87 | PRKD2 | 0.63965780 |
88 | CDK12 | 0.63619879 |
89 | CAMKK1 | 0.62954019 |
90 | IRAK2 | 0.62930755 |
91 | ICK | 0.61418824 |
92 | INSRR | 0.60344444 |
93 | MATK | 0.59822014 |
94 | MAP3K1 | 0.59695514 |
95 | KSR1 | 0.58978694 |
96 | MAPKAPK3 | 0.58693316 |
97 | MAP3K3 | 0.58617579 |
98 | RPS6KL1 | 0.58135005 |
99 | RPS6KC1 | 0.58135005 |
100 | MAP3K11 | 0.57262987 |
101 | PDK1 | 0.56438653 |
102 | CDK6 | 0.56306594 |
103 | FYN | 0.56245492 |
104 | TNK2 | 0.55552699 |
105 | PDGFRB | 0.55041280 |
106 | SGK2 | 0.53395100 |
107 | PDGFRA | 0.52372441 |
108 | ALK | 0.52094164 |
109 | IRAK4 | 0.51470542 |
110 | SGK3 | 0.50935203 |
111 | TRPM7 | 0.50464182 |
112 | MAPK4 | 0.49936342 |
113 | STK11 | 0.49265130 |
114 | FES | 0.49043167 |
115 | BMX | 0.48697841 |
116 | BRD4 | 0.47252406 |
117 | MTOR | 0.45381028 |
118 | NME2 | 0.45109755 |
119 | STK4 | 0.42930276 |
120 | PHKG2 | 0.42848971 |
121 | PHKG1 | 0.42848971 |
122 | LYN | 0.41543430 |
123 | CDK19 | 0.40041646 |
124 | PRKD1 | 0.39434691 |
125 | TYRO3 | 0.39373205 |
126 | RPS6KB2 | 0.39236925 |
127 | MAP2K4 | 0.38859362 |
128 | DYRK1B | 0.33917996 |
129 | PRKAA1 | 0.32212757 |
130 | CDK9 | 0.31330521 |
131 | RPS6KA6 | 0.30312830 |
132 | TGFBR1 | 0.30218701 |
133 | CLK1 | 0.29744380 |
134 | MAP3K8 | 0.28727920 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.51249383 |
2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.92229806 |
3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.74600501 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.46377808 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.20332194 |
6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.16437127 |
7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.13985060 |
8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.94423560 |
9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.89601623 |
10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.86190713 |
11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.83301227 |
12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.82194388 |
13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.78244802 |
14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.78156988 |
15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.74118219 |
16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.58527617 |
17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.58338211 |
18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.56763966 |
19 | Malaria_Homo sapiens_hsa05144 | 1.55971074 |
20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.55012649 |
21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.53700440 |
22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.52181311 |
23 | Insulin resistance_Homo sapiens_hsa04931 | 1.51460585 |
24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.50685182 |
25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.48814262 |
26 | ABC transporters_Homo sapiens_hsa02010 | 1.48183571 |
27 | Leishmaniasis_Homo sapiens_hsa05140 | 1.45331270 |
28 | * Measles_Homo sapiens_hsa05162 | 1.43178679 |
29 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.41086141 |
30 | Lysine degradation_Homo sapiens_hsa00310 | 1.36847044 |
31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.32545018 |
32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.30765656 |
33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.27810297 |
34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.23675350 |
35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.22781429 |
36 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.21194107 |
37 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.20577806 |
38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.16571735 |
39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.11998187 |
40 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.11315389 |
41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.09889841 |
42 | Endometrial cancer_Homo sapiens_hsa05213 | 1.08653722 |
43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.08532776 |
44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.06970013 |
45 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.06049144 |
46 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.05901674 |
47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.05771185 |
48 | Peroxisome_Homo sapiens_hsa04146 | 1.02757534 |
49 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.01550486 |
50 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98657512 |
51 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.97681868 |
52 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96934257 |
53 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.95778317 |
54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.95243444 |
55 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.94729518 |
56 | Bile secretion_Homo sapiens_hsa04976 | 0.93989748 |
57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92108326 |
58 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.92041351 |
59 | Colorectal cancer_Homo sapiens_hsa05210 | 0.91862069 |
60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.91297270 |
61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.88709725 |
62 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.88523547 |
63 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86762532 |
64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86584589 |
65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.86545357 |
66 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.86429915 |
67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.83558409 |
68 | Platelet activation_Homo sapiens_hsa04611 | 0.83391037 |
69 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.83370234 |
70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83309881 |
71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.82747948 |
72 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.82600667 |
73 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82242150 |
74 | Shigellosis_Homo sapiens_hsa05131 | 0.79669123 |
75 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.79621982 |
76 | Asthma_Homo sapiens_hsa05310 | 0.79278960 |
77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78928081 |
78 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.78470461 |
79 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.77924580 |
80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.77672414 |
81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75994697 |
82 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.75106440 |
83 | Phagosome_Homo sapiens_hsa04145 | 0.74479911 |
84 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.74286345 |
85 | Glioma_Homo sapiens_hsa05214 | 0.73843641 |
86 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.72718327 |
87 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72057170 |
88 | Legionellosis_Homo sapiens_hsa05134 | 0.71653797 |
89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71438195 |
90 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.71287463 |
91 | Influenza A_Homo sapiens_hsa05164 | 0.70528592 |
92 | Long-term potentiation_Homo sapiens_hsa04720 | 0.70339102 |
93 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70321360 |
94 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69831955 |
95 | Prostate cancer_Homo sapiens_hsa05215 | 0.69541913 |
96 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.69068350 |
97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68540768 |
98 | Thyroid cancer_Homo sapiens_hsa05216 | 0.68103941 |
99 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68069996 |
100 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.67842646 |
101 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67770391 |
102 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65188212 |
103 | * Hepatitis B_Homo sapiens_hsa05161 | 0.64929011 |
104 | Histidine metabolism_Homo sapiens_hsa00340 | 0.64497651 |
105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64116367 |
106 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63895202 |
107 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.63687197 |
108 | Endocytosis_Homo sapiens_hsa04144 | 0.62861850 |
109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61801016 |
110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61452733 |
111 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61064871 |
112 | Apoptosis_Homo sapiens_hsa04210 | 0.60040206 |
113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58998223 |
114 | Salmonella infection_Homo sapiens_hsa05132 | 0.58741350 |
115 | Amoebiasis_Homo sapiens_hsa05146 | 0.58000585 |
116 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.55672824 |
117 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55663058 |
118 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.55483472 |
119 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55192233 |
120 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55163836 |
121 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54597614 |
122 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54591601 |
123 | Hepatitis C_Homo sapiens_hsa05160 | 0.54174174 |
124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53669182 |
125 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53100525 |
126 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51283895 |
127 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51066219 |
128 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50855843 |
129 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50431781 |
130 | Pertussis_Homo sapiens_hsa05133 | 0.50337878 |
131 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50209097 |
132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49393293 |
133 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49371560 |
134 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.49039328 |
135 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48333418 |
136 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.47978010 |
137 | Allograft rejection_Homo sapiens_hsa05330 | 0.47282724 |
138 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47046308 |
139 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46766667 |
140 | Tuberculosis_Homo sapiens_hsa05152 | 0.43940345 |
141 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43138388 |
142 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42811348 |
143 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42164418 |
144 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.42120828 |
145 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41816902 |
146 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41793983 |
147 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40179752 |